Impact Banner

Newsroom

Welcome to the OREF Newsroom where you'll find news and announcements by and about OREF. Contact our Communications team with questions or media requests.


Karen Pubentz
Vice President, Communications
pubentz@oref.org

Amy Kile
Marketing Communications Manager
kile@oref.org

Stephanie Vazquez
Marketing Communications Specialist
vazquez@oref.org

News & Press Releases

Featured Articles

Scott P. Bruder, MD, PhD, Awarded 2027 ORS/OREF Distinguished Investigator Award

The award recognizes Dr. Bruder’s contributions to the field of orthopaedic research, to the ORS, and the OREF
10-22-26 | Updated: 11-20-2026

The Orthopaedic Research Society (ORS) and OREF awarded the 2027 ORS/OREF Distinguished Investigator Award to Scott P. Bruder, MD, PhD, FORS, FNAI, FAIMBE, who is General Manager of Regenerative Medicine at Dark Horse Consulting Group, for his contributions to the field of orthopaedic research, to the ORS and the OREF.


Dr. Bruder is a product developer whose laboratory work in mesenchymal stem cell biology has translated into commercial orthobiologic products used worldwide. His patents on the use of mesenchymal stem cells in orthopaedic conditions moved the field of orthopaedics from autologous to allogenic cell therapy. He has published more than 125 papers, abstracts and chapters, and his inventions and technologies have been the start for dozens of lucrative products.


For 20 years, Dr. Bruder has held senior leadership roles at Fortune 500 companies, beginning as the first scientist at Osiris Therapeutics. At Johnson & Johnson, he and his team established J&J Regenerative Therapeutics. He served as Chief Science & Technology Officer at Becton, Dickinson and Company (BD) and Chief Scientific and Medical Officer at Stryker.


Dr. Burder served on numerous ORS committees, championing academic industry and collaboration with the Food and Drug Administration. He has received highest scientific honors from ORS, the American Academy of Orthopaedic Surgeons, the Association of Bone and Joint Surgeons the American Institute for Medical and Biomedical Engineering and his alma Matter Case Western, where he earned his medical degree and doctorate. He trained in the laboratory of Arnold Caplan, PhD, after earning a ScB in biological sciences at Brown University. He has been an Adjunct Professor of Orthopaedics and/or Biomedical Engineering at Case since 1994.


The ORS/OREF Distinguished Investigator Award is selected by a review team comprising five individuals, including the most recent ORS/OREF Distinguished Investigator Award honoree, representatives of the OREF Research Grant Committee, representatives from the ORS Awards and Recognition Committee and an ad hoc review chair. The award honors an individual who has significantly contributed to the field of orthopaedic research, to the ORS, and the OREF through their outstanding scientific achievements and their commitment of time and service

 

Orthopaedic Partner News

OREF is pleased to share news from our orthopaedic partners.

 

Scott P. Bruder, MD, PhD, Awarded 2027 ORS/OREF Distinguished Investigator Award

Nov 20, 2026, 17:47 PM
The award recognizes Dr. Bruder’s contributions to the field of orthopaedic research, to the ORS, and the OREF
Title : Scott P. Bruder, MD, PhD, Awarded 2027 ORS/OREF Distinguished Investigator Award
Post author :
Publish Date : 10-22-26

The Orthopaedic Research Society (ORS) and OREF awarded the 2027 ORS/OREF Distinguished Investigator Award to Scott P. Bruder, MD, PhD, FORS, FNAI, FAIMBE, who is General Manager of Regenerative Medicine at Dark Horse Consulting Group, for his contributions to the field of orthopaedic research, to the ORS and the OREF.


Dr. Bruder is a product developer whose laboratory work in mesenchymal stem cell biology has translated into commercial orthobiologic products used worldwide. His patents on the use of mesenchymal stem cells in orthopaedic conditions moved the field of orthopaedics from autologous to allogenic cell therapy. He has published more than 125 papers, abstracts and chapters, and his inventions and technologies have been the start for dozens of lucrative products.


For 20 years, Dr. Bruder has held senior leadership roles at Fortune 500 companies, beginning as the first scientist at Osiris Therapeutics. At Johnson & Johnson, he and his team established J&J Regenerative Therapeutics. He served as Chief Science & Technology Officer at Becton, Dickinson and Company (BD) and Chief Scientific and Medical Officer at Stryker.


Dr. Burder served on numerous ORS committees, championing academic industry and collaboration with the Food and Drug Administration. He has received highest scientific honors from ORS, the American Academy of Orthopaedic Surgeons, the Association of Bone and Joint Surgeons the American Institute for Medical and Biomedical Engineering and his alma Matter Case Western, where he earned his medical degree and doctorate. He trained in the laboratory of Arnold Caplan, PhD, after earning a ScB in biological sciences at Brown University. He has been an Adjunct Professor of Orthopaedics and/or Biomedical Engineering at Case since 1994.


The ORS/OREF Distinguished Investigator Award is selected by a review team comprising five individuals, including the most recent ORS/OREF Distinguished Investigator Award honoree, representatives of the OREF Research Grant Committee, representatives from the ORS Awards and Recognition Committee and an ad hoc review chair. The award honors an individual who has significantly contributed to the field of orthopaedic research, to the ORS, and the OREF through their outstanding scientific achievements and their commitment of time and service

 

Categories :
Scott P. Bruder, MD, PhD, FORS, FNAI, FAIMBE, recipient of the 2027 ORS/OREF Distinguished Investigator Award
Related News and Press Releases
Load more comments
Comment by from